22 May 2013
Keywords: gsk, early-stage, hiv, drugs, show, promise, glaxosmithkline
Article | 21 July 2003
GlaxoSmithKline presented positive data on three new HIV agents at the 2nd International AIDS Society Conference on HIV Pathogenesis and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 July 2003
21 May 2013
© 2013 thepharmaletter.com